Unknown

Dataset Information

0

Potent HIV-1 protease inhibitors incorporating meso-bicyclic urethanes as P2-ligands: structure-based design, synthesis, biological evaluation and protein-ligand X-ray studies.


ABSTRACT: Recently, we designed a series of novel HIV-1 protease inhibitors incorporating a stereochemically defined bicyclic fused cyclopentyl (Cp-THF) urethane as the high affinity P2-ligand. Inhibitor with this P2-ligand has shown very impressive potency against multi-drug-resistant clinical isolates. Based upon the -bound HIV-1 protease X-ray structure, we have now designed and synthesized a number of meso-bicyclic ligands which can conceivably interact similarly to the Cp-THF ligand. The design of meso-ligands is quite attractive as they do not contain any stereocenters. Inhibitors incorporating urethanes of bicyclic-1,3-dioxolane and bicyclic-1,4-dioxane have shown potent enzyme inhibitory and antiviral activities. Inhibitor (K(i) = 0.11 nM; IC(50) = 3.8 nM) displayed very potent antiviral activity in this series. While inhibitor showed comparable enzyme inhibitory activity (K(i) = 0.18 nM) its antiviral activity (IC(50) = 170 nM) was significantly weaker than inhibitor . Inhibitor maintained an antiviral potency against a series of multi-drug resistant clinical isolates comparable to amprenavir. A protein-ligand X-ray structure of -bound HIV-1 protease revealed a number of key hydrogen bonding interactions at the S2-subsite. We have created an active model of inhibitor based upon this X-ray structure.

SUBMITTER: Ghosh AK 

PROVIDER: S-EPMC2797486 | biostudies-literature | 2008 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Potent HIV-1 protease inhibitors incorporating meso-bicyclic urethanes as P2-ligands: structure-based design, synthesis, biological evaluation and protein-ligand X-ray studies.

Ghosh Arun K AK   Gemma Sandra S   Takayama Jun J   Baldridge Abigail A   Leshchenko-Yashchuk Sofiya S   Miller Heather B HB   Wang Yuan-Fang YF   Kovalevsky Andrey Y AY   Koh Yashiro Y   Weber Irene T IT   Mitsuya Hiroaki H  

Organic & biomolecular chemistry 20080811 20


Recently, we designed a series of novel HIV-1 protease inhibitors incorporating a stereochemically defined bicyclic fused cyclopentyl (Cp-THF) urethane as the high affinity P2-ligand. Inhibitor with this P2-ligand has shown very impressive potency against multi-drug-resistant clinical isolates. Based upon the -bound HIV-1 protease X-ray structure, we have now designed and synthesized a number of meso-bicyclic ligands which can conceivably interact similarly to the Cp-THF ligand. The design of me  ...[more]

Similar Datasets

| S-EPMC3164320 | biostudies-literature
| S-EPMC3433276 | biostudies-literature
| S-EPMC3800042 | biostudies-literature
| S-EPMC6711809 | biostudies-literature
| S-EPMC6237192 | biostudies-literature
| S-EPMC6541917 | biostudies-literature
| S-EPMC3862176 | biostudies-literature
| S-EPMC5617771 | biostudies-literature
| S-EPMC4133278 | biostudies-literature
| S-EPMC3179850 | biostudies-literature